213 related articles for article (PubMed ID: 22484291)
21. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment.
Wong JY; Kuzel P; Mullen J; Lien D; Mahmood M; Conrad C; Fiorillo L
Pediatr Transplant; 2014 Sep; 18(6):E200-7. PubMed ID: 25039541
[TBL] [Abstract][Full Text] [Related]
22. [Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Papy E; Carde A; Ribaud P; Faure P; Touratier S
Presse Med; 2006 Feb; 35(2 Pt 1):251-2. PubMed ID: 16493359
[No Abstract] [Full Text] [Related]
23. Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
Kuklinski LF; Li S; Karagas MR; Weng WK; Kwong BY
J Am Acad Dermatol; 2017 Oct; 77(4):706-712. PubMed ID: 28780363
[TBL] [Abstract][Full Text] [Related]
24. Voriconazole phototoxicity in children: a retrospective review.
Sheu J; Hawryluk EB; Guo D; London WB; Huang JT
J Am Acad Dermatol; 2015 Feb; 72(2):314-20. PubMed ID: 25481710
[TBL] [Abstract][Full Text] [Related]
25. Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
Patel AR; Turner ML; Baird K; Gea-Banacloche J; Mitchell S; Pavletic SZ; Wise B; Cowen EW
Biol Blood Marrow Transplant; 2009 Mar; 15(3):370-6. PubMed ID: 19203729
[TBL] [Abstract][Full Text] [Related]
26. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.
Williams K; Mansh M; Chin-Hong P; Singer J; Arron ST
Clin Infect Dis; 2014 Apr; 58(7):997-1002. PubMed ID: 24363331
[TBL] [Abstract][Full Text] [Related]
27. Management of voriconazole hepatotoxicity in a lung transplant patient.
Belaiche S; Roustit M; Bedouch P; Quetant S; Saint-Raymond C; Pison C
Transpl Infect Dis; 2011 Jun; 13(3):309-11. PubMed ID: 21176020
[TBL] [Abstract][Full Text] [Related]
28. Voriconazole in the treatment of invasive fungal infections.
Keady S; Thacker M
Intensive Crit Care Nurs; 2005 Dec; 21(6):370-3. PubMed ID: 15985371
[TBL] [Abstract][Full Text] [Related]
29. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
31. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Ayub A; Kenney CV; McKiernan FE
J Clin Rheumatol; 2011 Mar; 17(2):73-5. PubMed ID: 21169844
[TBL] [Abstract][Full Text] [Related]
32. [Voriconazole safety: short review of clinical data].
Veselov AV; Belousov DIu
Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257
[No Abstract] [Full Text] [Related]
33. Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients.
Luong ML; Hosseini-Moghaddam SM; Singer LG; Chaparro C; Azad S; Lazar N; Boutros PC; Keshavjee S; Rotstein C; Husain S
Am J Transplant; 2012 Jul; 12(7):1929-35. PubMed ID: 22486950
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
Gorski E; Esterly JS; Postelnick M; Trifilio S; Fotis M; Scheetz MH
Antimicrob Agents Chemother; 2011 Jan; 55(1):184-9. PubMed ID: 20974867
[TBL] [Abstract][Full Text] [Related]
35. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
McCarthy KL; Playford EG; Looke DF; Whitby M
Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
[TBL] [Abstract][Full Text] [Related]
36. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
[No Abstract] [Full Text] [Related]
37. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W
J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946
[TBL] [Abstract][Full Text] [Related]
38. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
[TBL] [Abstract][Full Text] [Related]
39. Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
Michael C; Bierbach U; Frenzel K; Lange T; Basara N; Niederwieser D; Mauz-Körholz C; Preiss R
Antimicrob Agents Chemother; 2010 Aug; 54(8):3225-32. PubMed ID: 20547816
[TBL] [Abstract][Full Text] [Related]
40. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Pongas GN; Lewis RE; Samonis G; Kontoyiannis DP
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():93-7. PubMed ID: 19754766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
